A reassessment of ticarcillin/clavulanic acid dose recommendations for infants, children and adults.
Reed
M D
MD
Rainbow Babies and Children's Hospital, Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-6010, USA.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination / Q000008:administration & dosage* / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010372:Pediatrics / Q000379:methods; D013982:Ticarcillin / Q000008:administration & dosage / Q000494:pharmacology; D016896:Treatment Outcome
D002969:Clavulanic Acids; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin